Frontal fibrosing alopecia usually affects post-menopausal women. However, approximately 20% of female patients are pre-menopausal and 10% are men with distinctive presentation. Treatment options differ among patients and has to be individualized.
For further reading on treatment updates; refer to articles by Murad et al: (references in bibliography section)
1) JOURNAL EDITOR'S PICK OF THE YEAR 2018:
5 ALPHA‐REDUCTASE INHIBITOR TREATMENT FOR FRONTAL FIBROSING ALOPECIA: AN EVIDENCE‐BASED TREATMENT UPDATE. (JEADV)
2) REPLY TO EFFECTIVENESS OF DUTASTERIDE IN LARGE SERIES OF PATIENTS WITH FRONTAL FIBROSING ALOPECIA IN REAL CLINICAL PRACTICE. (JAAD)
3) FRONTAL FIBROSING ALOPECIA IN BREAST CANCER PATIENTS ON AROMATASE‐INHIBITOR. (JEADV)
4) PROSTAGLANDIN ANALOGUE FOR TREATMENT OF EYEBROW LOSS IN FRONTAL FIBROSING ALOPECIA: 3 CASES WITH DIFFERENT OUTCOMES. (JEADV)
5) WOOD’S LIGHT EXAMINATION FOR ASSESSMENT IN FRONTAL FIBROSING ALOPECIA: A MANOEUVRE TO ENHANCE THE HAIRLINE. (JAAD)